About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

A new study compares body mass index (BMI) with body fat percentage and finds the latter is far more reliable in predicting ...

HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

Rhythm Pharmaceuticals is advancing its oral obesity drug bivamelagon to Phase III studies after it significantly reduced body mass index (BMI) in all three doses.

A prospective cohort study found that stratifying BMI categories by BMI-specific waist circumference thresholds modestly ...

Paternal obesity was associated with rapid BMI growth trajectories among offspring, especially in the presence of maternal obesity.

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...

A WHO-backed study reveals that overweight postmenopausal women with heart disease face a 31 per cent higher breast cancer ...

A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.

Sarcopenic obesity, a hidden condition affecting people over 40, causes muscle loss and fat gain without major weight changes ...